Ginkgo Bioworks Holdings, Inc. ( DNA) - Key Metrics
DNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.60 | -$1.46 | -$0.86 | -$1.14 |
| 2025Q3 | $0.70 | -$1.45 | -$0.57 | -$0.57 |
| 2025Q2 | $0.90 | -$1.10 | -$0.73 | -$0.73 |
| 2025Q1 | $0.89 | -$1.68 | -$0.95 | -$1.09 |
DNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.43 |
| 2025Q3 | ? | -2.51 |
| 2025Q2 | ? | -2.56 |
| 2025Q1 | ? | -0.85 |
DNA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -13.25% | ? |
| 2025Q4 | -13.67% | ? |
| 2025Q3 | -3.90% | ? |
| 2025Q2 | -6.53% | ? |
| 2025Q1 | -19.13% | ? |
DNA
Price: $8.24
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.38 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 21.0 million
Market Capitalization: 537.0 million